This
page
is
part
of
the
Continuous
Integration
Build
of
FHIR
Specification
(v4.0.1:
R4
-
Mixed
Normative
and
STU
)
in
it's
permanent
home
(it
will
always
(will
be
available
incorrect/inconsistent
at
this
URL).
The
current
version
which
supercedes
this
version
is
5.0.0
.
For
a
full
list
of
available
versions,
see
times).
See
the
Directory
of
published
versions
.
Page
versions:
R5
R4B
R4
R3
R2
| Responsible Owner: Pharmacy Work Group | Standards Status : Informative |
Compartments
:
|
This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile Medication .
Generated
Narrative
with
Details
Narrative:
Medication
medexample015
code
:
Capecitabine
500mg
oral
tablet
(Xeloda)
(Details
:
{RxNorm
code
'213293'
=
'Xeloda
capecitabine
500
MG
Oral
Tablet',
given
as
'Capecitabine
500mg
oral
tablet
(Xeloda)'})
Tablet
[Xeloda]
manufacturer
marketingAuthorizationHolder
:
id:
org2;
name:
Gene
Inc
Organization
Medication
Manufacturer
form
doseForm
:
Tablet
(basic
dose
form
(qualifier
value)
(Details
:
{SNOMED
CT
code
'385055001'
=
'Tablet',
given
as
'Tablet
dose
form
(qualifier
value)'})
form)
ingredient
IngredientsItems
Item[x] StrengthReferenceid: sub04;Substance Capecitabine (substance)(Details : {SNOMED CT code '386906001' = 'Capecitabine', given as 'Capecitabine (substance)'})strength : 500 mg (Details: UCUM
code mgcodemg = 'mg')/1/1(unit TAB from http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm) (Details:http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm code TABOrderable Drug Form codeTAB = 'Tablet')
| LotNumber | ExpirationDate |
| 9494788 | 2017-05-22 |
Generated Narrative: Organization #mmanu
name : Medication Manufacturer
Generated Narrative: Substance #sub04
Codes
22/05/2017ConceptCapecitabine (substance)
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.